subscribe
 

Switching drugs improves breast cancer patient survival rates

Trial examined the long-term effectiveness of switching to exemestane after two to three years of tamoxifen



Expanding patient pool ensures stable growth for European Cardiac Patient Monitoring Market

Advanced applications to drive market revenues to $583.6m by 2016, says Frost & Sullivan



Patient trials of new leukaemia cancer vaccine

Treatment will use a new DNA vaccine which will treat a selected group of volunteers who have either chronic or acute myeloid leukaemia



call for better patient access to innovative technologies

Eucomed, the European Medical Technology Industry Association, has called on EU decision-makers to encourage and actively promote equitable and timely patient and clinician access to existing medical technologies for Parkinson's Disease, and more research into new therapies.



Subscribe

Subscribe



Newsbrief

FREE NEWSBRIEF SUBSCRIPTION

To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited
subscribe